Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Sansure Biotech’s HPV DNA Diagnostic Kit (HPV 13+2) approved by the NMPA

Sansure Biotech’s HPV DNA Diagnostic Kit (HPV 13+2) was approved by the China NMPA on January 6, with reference to the medical device approval released on the NMPA’s official website. This is another blockbuster product from Sansure Biotech in promoting the global elimination of cervical cancer. In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer, […]

Sansure Biotech’s SARS-CoV-2 Rapid Antigen Test Included in EU HSC Common List

On December 21,  a SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method) developed by Sansure Biotech was included in EU Health Security Committee (HSC) Common List. Hence, the product has been accredited by yet another international certification body, following its CE certification and inclusion in the common lists of the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) […]

Sansure Biotech’s SARS-CoV-2 and Influenza A/B Virus Nucleic Acid Diagnostic Kit was approved by China NMPA for marketing

The kit developed by Sansure Biotech for nucleic acid detection of SARS-CoV-2, and influenza A & B virus (PCR-Fluorescence Probing) was approved by the National Medical Products Administration (NMPA) for marketing on December 17. It has also received CE mark and is expected to provide critical support for global COVID-19 prevention and control. According to WHO estimates, influenza causes 3 to 5 […]

Results come out in 15 minutes! Two SARS-CoV-2 antibody detection kits of Sansure Biotech received CE mark

On December 8, Sansure Biotech’s SARS-CoV-2 Neutralizing Antibodies Test (Colloidal Gold) and SARS-CoV-2 S-RBD Antibodies Test (Colloidal Gold) passed CE certification and received the certificate. This is the first batch of antibody products in the company’s immune product line to receive international authoritative registration certificate following the antigen detection kits receiving CE certification, which further enriches the company’s immune product […]

Targeted Blockage! Sansure solution for detecting SARS-CoV-2 variant “Omicron”

On local time November 26, WHO held an emergency session and released a statement in which the SARS-CoV-2 variant B.1.1.529 was listed as a “Variant of Concern” and named after the Greek letter Omicron. According to WHO, the Omicron variant was first reported in South Africa. Preliminary studies showed that the variant has increased the risk of SARS-CoV-2 infection in […]

Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.

Thank you!

We shall contact you soon!
Back Top